Article Versions Notes

Bironzo P, Reale ML, Sperone T, Tabbò F, Caglio A, Listì A, Passiglia F, Di Maio M, Righi L, Bussolino F, et al. Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-Mutations. Cancers. 2021; 13(10):2425. https://doi.org/10.3390/cancers13102425

Bironzo, Paolo, Maria Lucia Reale, Tessa Sperone, Fabrizio Tabbò, Andrea Caglio, Angela Listì, Francesco Passiglia, Massimo Di Maio, Luisella Righi, Federico Bussolino, and et al. 2021. "Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-Mutations" Cancers 13, no. 10: 2425. https://doi.org/10.3390/cancers13102425

Bironzo, P., Reale, M. L., Sperone, T., Tabbò, F., Caglio, A., Listì, A., Passiglia, F., Di Maio, M., Righi, L., Bussolino, F., Scagliotti, G. V., & Novello, S. (2021). Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-Mutations. Cancers, 13(10), 2425. https://doi.org/10.3390/cancers13102425